The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis
Luah, Xiao Wen, Holst‐Hansen, Thomas, Lübker, Christopher
Published in Diabetes, obesity & metabolism (01.06.2024)
Published in Diabetes, obesity & metabolism (01.06.2024)
Get full text
Journal Article
Treatment effect of semaglutide 2.4 mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights
Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Holst‐Hansen, Thomas, Olivieri, Anamaria‐Vera, Manton, Andrew
Published in Diabetes, obesity & metabolism (01.04.2024)
Published in Diabetes, obesity & metabolism (01.04.2024)
Get full text
Journal Article
Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity
Wilkinson, Lua, Holst‐Hansen, Thomas, Laursen, Peter N., Rinnov, Anders R., Batterham, Rachel L., Garvey, W. Timothy
Published in Obesity (Silver Spring, Md.) (01.09.2023)
Published in Obesity (Silver Spring, Md.) (01.09.2023)
Get full text
Journal Article
Impact of Zygosity on Bimodal Phenotype Distributions
Holst-Hansen, Thomas, Abad, Elena, Muntasell, Aura, López-Botet, Miguel, Jensen, Mogens H., Trusina, Ala, Garcia-Ojalvo, Jordi
Published in Biophysical journal (11.07.2017)
Published in Biophysical journal (11.07.2017)
Get full text
Journal Article
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Knop, Filip K, Aroda, Vanita R, do Vale, Ruben D, Holst-Hansen, Thomas, Laursen, Peter N, Rosenstock, Julio, Rubino, Domenica M, Garvey, W Timothy
Published in The Lancet (British edition) (26.08.2023)
Published in The Lancet (British edition) (26.08.2023)
Get full text
Journal Article
Treatment effect of semaglutide 2.4mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights
Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Thomas Holst‐Hansen, Anamaria‐Vera Olivieri, Manton, Andrew
Published in Diabetes, obesity & metabolism (01.04.2024)
Published in Diabetes, obesity & metabolism (01.04.2024)
Get full text
Journal Article
Impact of Oral Semaglutide 50 mg on Prediabetes According to Weight Loss Category: OASIS 1 Trial
Rosenstock, Julio, Frias, Juan, Garvey, W Timothy, Holst-Hansen, Thomas, Rinnov, Anders Rasmussen, Traina, Andrea, Knop, Filip Krag
Published in Obesity (Silver Spring, Md.) (01.11.2023)
Get full text
Published in Obesity (Silver Spring, Md.) (01.11.2023)
Journal Article
Once-Daily Oral Semaglutide 50 mg Improves Cardiovascular Risk Factors in Overweight/Obesity
Garvey, W Timothy, Soborg, Thomas Holst-Hansen, Karlsson, Tobias, Hellerup, Filip Krag Knop, Copenhagen, Naveen Rathor, Rubino, Domenica, Rosenstock, Julio
Published in Obesity (Silver Spring, Md.) (01.11.2023)
Get full text
Published in Obesity (Silver Spring, Md.) (01.11.2023)
Journal Article
The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies
Kral, Pavol, Holst-Hansen, Thomas, Olivieri, Anamaria V., Ivanescu, Cristina, Lamotte, Mark, Larsen, Sara
Published in Advances in therapy (01.11.2024)
Published in Advances in therapy (01.11.2024)
Get full text
Journal Article
Spatiotemporal NF-κB dynamics encodes the position, amplitude, and duration of local immune inputs
Son, Minjun, Frank, Tino, Holst-Hansen, Thomas, Wang, Andrew G, Junkin, Michael, Kashaf, Sara S, Trusina, Ala, Tay, Savaş
Published in Science advances (02.09.2022)
Published in Science advances (02.09.2022)
Get full text
Journal Article